From week 4 onwards, the dose can be adjusted in 2.5 mg increments every 4 weeks, up to a maximum of 15 mg weekly, based on your specific needs and response to treatment
Kidney Int 101(4):804813
Researchers from Brigham conducted a meta-analysis of 15 randomized studies involving patients taking GLP-1 medications, which are commonly used for type 2 diabetes and weight loss
In 2023, a randomized, double-blind, placebo-controlled, multicenter trial investigated the efficacy of tirzepatide over 24 weeks in patients with moderate-to-severe obesity and OSAS
Mice were neonatally exposed to acetaminophen and experienced spontaneous behavior, worsened memory, and learning and cognitive difficulties
Violante S, Ijlst L, Te Brinke H, Koster J, Tavares de Almeida I, Wanders RJA, et al